title: Dorsolateral prefrontal N-acetyl-aspartate concentration in male patients with chronic schizophrenia and with chronic bipolar disorder.
abstract: OBJECTIVE
  A study of N-acetyl-aspartate (NAA) can provide data of interest about cortical alterations in psychotic illnesses. Although a decreased NAA level in the cerebral cortex is a replicated finding in chronic schizophrenia, the data are less consistent for bipolar disease. On the other hand, it is likely that NAA values in schizophrenia may differ in men and women.
  
  
  METHODS
  We used proton magnetic resonance spectroscopy ((1)H MRS) to examine NAA levels in the prefrontal cortex in two groups of male patients, one with schizophrenia (n=11) and the other with bipolar disorder (n=13) of similar duration, and compared them to a sample of healthy control males (n=10). Additionally, we compared the degree of structural deviations from normal volumes of gray matter (GM) and cerebrospinal fluid (CSF) in the dorsolateral prefrontal cortex.
  
  
  RESULTS
  Compared to controls, schizophrenia and bipolar patients presented decreased NAA to creatine ratios, while only the schizophrenia group showed an increase in CSF in the dorsolateral prefrontal region. There were no differences in choline to creatine ratios among the groups.
  
  
  CONCLUSIONS
  These data suggest that the decrease in NAA in the prefrontal region may be similar in schizophrenia and bipolar disorder, at least in the chronic state. However, cortical CSF may be markedly increased in schizophrenia patients.
authors: Department of Psychiatry, Hospital Clínico Universitario, Paseo de San Vicente 58-182, E-37007 Salamanca, Spain. vmolina@usal.es
authors: V
authors: V
authors: Molina
authors: J
authors: J
authors: Sánchez
authors: J
authors: J
authors: Sanz
authors: S
authors: S
authors: Reig
authors: C
authors: C
authors: Benito
authors: I
authors: I
authors: Leal
authors: F
authors: F
authors: Sarramea
authors: R
authors: R
authors: Rebolledo
authors: T
authors: T
authors: Palomo
authors: M
authors: M
authors: Desco
mesh_terms: D000328:Adult; D001224:Aspartic Acid / Q000031:analogs & derivatives* / Q000378:metabolism; D001714:Bipolar Disorder / Q000175:diagnosis / Q000473:pathology / Q000503:physiopathology*; D002555:Cerebrospinal Fluid / Q000502:physiology; D002794:Choline / Q000378:metabolism; D002908:Chronic Disease; D003401:Creatine / Q000378:metabolism; D005583:Fourier Analysis; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008279:Magnetic Resonance Imaging; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D009413:Nerve Fibers, Myelinated / Q000473:pathology; D017397:Prefrontal Cortex / Q000473:pathology / Q000503:physiopathology*; D012016:Reference Values; D012559:Schizophrenia / Q000175:diagnosis / Q000473:pathology / Q000503:physiopathology*
chemical_list: D001224:Aspartic Acid; C000179:N-acetylaspartate; D003401:Creatine; D002794:Choline